Approach to critical illness myopathy and polyneuropathy in the older SARS-CoV-2 patients
- 1 September 2020
- journal article
- review article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 79, 241-245
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patientsCritical Care, 2014
- Axon degeneration: Molecular mechanisms of a self-destruction pathwayJournal of Cell Biology, 2012
- Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysisThe Lancet Neurology, 2011
- Critical illness myopathy: Further evidence from muscle‐fiber excitability studies of an acquired channelopathyMuscle & Nerve, 2007
- Molecular and cellular defects of skeletal muscle in an animal model of acute quadriplegic myopathyMuscle & Nerve, 2006
- The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunizationMolecular Immunology, 2006
- Quadriplegic areflexic ICU illness: Selective thick filament loss and normal nerve histologyMuscle & Nerve, 2002
- Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levelsCritical Care Medicine, 2000
- Loss of electrical excitability in an animal model of acute quadriplegic myopathyAnnals of Neurology, 1998
- Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuroniumNeuromuscular Disorders, 1992